Precigen
Precision medicines using targeted therapeutic approaches for difficult-to-treat diseases
New patent ·
- Sector
- Agritech
- Headquarters
- GERMANTOWN, MD
- Latest Form D
- $13M, Dec 2020
- Total capital
- $466M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $466M
- 20 Form D · last Dec 2020
- 70 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 23
- 17 pending · first 2022
- Rank in peer group#2 of 52
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 20th filing$13M
- Private capital raisedForm D · SEC · 19th filing$35M
- Private capital raisedForm D · SEC · 18th filing$4.3M
- Private capital raisedForm D · SEC · 17th filing$21.6M
- Private capital raisedForm D · SEC · 16th filing$450K
- Private capital raisedForm D · SEC · 15th filing$10.2M
- Private capital raisedForm D · SEC · 14th filing$57.5M
- Private capital raisedForm D · SEC · 13th filing$28.6M
- Private capital raisedForm D · SEC · 12th filing$25M
- Private capital raisedForm D · SEC · 11th filing$64.4M
- Private capital raisedForm D · SEC · 10th filing$25M
- Private capital raisedForm D · SEC · 9th filing$17M
- Private capital raisedForm D · SEC · 8th filing$1.1M
- Private capital raisedForm D · SEC · 7th filing$17M
- Private capital raisedForm D · SEC · 6th filing$91.8M
- Private capital raisedForm D · SEC · 5th filing$550K
- Private capital raisedForm D · SEC · 4th filing$1M
- Private capital raisedForm D · SEC · 3rd filing$17.4M
- Private capital raisedForm D · SEC · 2nd filing$25M
- Private capital raisedForm D · SEC · 1st filing$10M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 52 peers
Line = medianAgritech · Platform
- Granted patents#2 · top 4%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Cesar L. AlvarezDirectorNamed in SEC Form D filings
- Dean J. MitchellDirectorNamed in SEC Form D filings
- Donald P. LehrExecutive OfficerNamed in SEC Form D filings
- Fred D. HassanDirectorNamed in SEC Form D filings
- Helen P. Sabzevari, Ph.D.Executive OfficerNamed in SEC Form D filings
- James S. TurleyDirectorNamed in SEC Form D filings
Show all 14 people
- Jeffrey B. KindlerDirectorNamed in SEC Form D filings
- Jeffrey P. PerezExecutive OfficerNamed in SEC Form D filings
- Randal J. KirkDirectorNamed in SEC Form D filings
- Rick L. SterlingExecutive OfficerNamed in SEC Form D filings
- Robert B. ShapiroDirectorNamed in SEC Form D filings
- Steven L. FrankDirectorNamed in SEC Form D filings
- Thomas P. Reed, Ph.D.Executive OfficerNamed in SEC Form D filings
- Vinita D. GuptaDirectorNamed in SEC Form D filings
What it has protected
USPTO · 23 granted of 40- New patentChimeric Receptor TherapyUSPTOUS 12,760,083
- GrantedFusion Constructs And Methods Of Using ThereofUSPTOUS 12,703,747
- PendingHuman Papillomavirus Vaccines And Uses Of The SameUSPTOApplication 19261890
Show all 40 patent records
- Chimeric Receptor TherapyOct 13, 2026 · US 12,760,083Granted
- Fusion Constructs And Methods Of Using ThereofAug 11, 2026 · US 12,703,747Granted
- Human Papillomavirus Vaccines And Uses Of The SameApr 9, 2026 · Application 19261890Pending
- Electroporation Apparatus And MethodMar 10, 2026 · US 12,570,945Granted
- CD33 Specific Chimeric Antigen ReceptorsFeb 24, 2026 · US 12,559,536Granted
- ROR-1 Specific Chimeric Antigen Receptors And Uses ThereofFeb 5, 2026 · Application 19077365Pending
- POLYCISTRONIC miRNA CONSTRUCTS FOR IMMUNE CHECKPOINT INHIBITIONDec 25, 2025 · Application 18992243Pending
- Fusion Constructs And Methods Of Using ThereofOct 23, 2025 · Application 18966676Pending
- Expression Of Novel Cell TagsOct 2, 2025 · Application 18953059Pending
- Human Papillomavirus Vaccines And Uses Of The SameSep 2, 2025 · US 12,404,306Granted
- Hepatitis B Vaccines And Uses Of The SameJul 10, 2025 · Application 19023657Pending
- ROR-1 Specific Chimeric Antigen Receptors And Uses ThereofApr 15, 2025 · US 12,275,772Granted
- Hepatitis B Vaccines And Uses Of The SameFeb 25, 2025 · US 12,234,261Granted
- Methods And Microorganisms For The Fermentation Of Methane To Multi-carbon CompoundsFeb 25, 2025 · US 12,234,465Granted
- Fusion Constructs And Methods Of Using ThereofJan 14, 2025 · US 12,194,094Granted
- Expression Of Novel Cell TagsDec 31, 2024 · US 12,180,517Granted
- Novel Adenovirus Vaccine Therapy For The Treatment Of Recurrent Respiratory PapillomatosisDec 5, 2024 · Application 18671685Pending
- Human Papillomavirus Vaccines And Uses Of The SameNov 28, 2024 · Application 18671275Pending
- MUC16 Specific Chimeric Antigen Receptors And Uses ThereofNov 7, 2024 · Application 18628575Pending
- Methods And Microorganisms For Making 1,4-BUTANEDIOL And Derivatives Thereof From C1 CarbonsNov 7, 2024 · Application 18661283Pending
- Recombinant Vectors Comprising Polycistronic Expression Cassettes and Methods of Use ThereofSep 26, 2024 · Application 18259985Pending
- Molecular SwitchesSep 17, 2024 · US 12,091,667Granted
- Expression Of Novel Cell TagsAug 13, 2024 · US 12,060,585Granted
- Method For Integration Of TransgenesAug 8, 2024 · Application 18426680Pending
- Methods And Microorganisms For Making 1,4-BUTANEDIOL And Derivatives Thereof From C1 CarbonsJun 25, 2024 · US 12,018,310Granted
- Frataxin Expression ConstructsJun 4, 2024 · US 11,998,618Granted
- Human Papilloma Virus Vaccines and Uses of the Same for HPV Associated DiseasesMay 30, 2024 · Application 18253624Pending
- MUC16 Specific Chimeric Antigen Receptors And Uses ThereofMay 14, 2024 · US 11,981,746Granted
- Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologiesMay 9, 2024 · Application 18485838Pending
- MUC16 Specific Chimeric Antigen Receptors And Uses ThereofMay 7, 2024 · US 11,976,134Granted
- Modulating Expression Of Polypeptides Via New Gene Switch Expression SystemsApr 2, 2024 · US 11,946,054Granted
- Methods And Microorganisms For Making 2,3-BUTANEDIOL And Derivatives Thereof From C1 CarbonsMar 26, 2024 · US 11,939,584Granted
- Frataxin Expression ConstructsJan 4, 2024 · Application 18357565Pending
- Polypeptide Compositions Comprising SpacersDec 28, 2023 · Application 18344421Pending
- CD33 Specific Chimeric Antigen ReceptorsOct 17, 2023 · US 11,787,848Granted
- Modulating Expression Of Polypeptides Via New Gene Switch Expression SystemsJul 4, 2023 · US 11,692,194Granted
- Hepatitis B Vaccines And Uses Of The SameMar 21, 2023 · US 11,608,362Granted
- Fusion Constructs And Methods Of Using ThereofDec 27, 2022 · US 11,535,669Granted
- Buffer Solutions For ElectroporationSep 8, 2022 · Application 17682793Pending
- Methods And Microorganisms For The Fermentation Of Methane To Multi-carbon CompoundsAug 23, 2022 · US 11,421,235Granted
Related companies, and why
- SupraSensor Technologies, LLCSimilar federal contract value in Agritech · null in contracts
- CONCURRENT SOLUTIONS, LLCSimilar federal contract value in Agritech · null in contracts
- Envonics LLCSimilar federal contract value in Agritech · null in contracts
- PATHHOUSE LLCSimilar federal contract value in Agritech · null in contracts
- CHI BOTANIC INC.Similar federal contract value in Agritech · null in contracts
- BREKLAND INCORPORATEDSimilar federal contract value in Agritech · null in contracts
Regulatory activity · Agritech
- Supplemental Disaster Assistance Programs, Marketing Assistance Loans, and Sugar ProvisionsCommodity Credit Corporation
- Revisions to the Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Loan ProgramRural Business-Cooperative Service
- Organic Certification Cost Share Program (OCCSP)Commodity Credit Corporation
- Technical Guidelines for the Production of Regenerative Agricultural Biofuel FeedstocksEnergy and Environmental Policy Office
- Rescinding Portions of U.S. Department of Agriculture Title VI Regulations To Conform More Closely With the Department of Justice's Regulations To Implement Executive Order 14281
- Assistance for Specialty Crop Farmers (ASCF) Program; Approval of Information Collection RequestCommodity Credit Corporation
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .